Search Results - F. Salva
- Showing 1 - 3 results of 3
-
1
Surrogate to predict overall survival in patients with BRAF V600E-mutant colorectal cancer treated with BRAF inhibitor combinations by J. Ros, V. Navarro, G. Villacampa, I. Baraibar, F. Salvà, M. Rodriguez, C. Vaghi, A. Garcia, A. Alcaraz, J. Tabernero, E. Élez, R. Dienstmann
Published in ESMO Gastrointestinal Oncology (2025-09-01)Get full text
Article -
2
Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases—the PURPLE trial by S. Kasper, E. Elez, U. Neumann, S. Lang, A.-K. Trampe, F. Salva, C. Dopazo, I. Virchow, S. Hartmann, K. Herrmann, J. Tabernero, A. Westendorf, M. Schuler, A. Schramm
Published in ESMO Gastrointestinal Oncology (2025-09-01)Get full text
Article -
3
Retreatment with oxaliplatin-based regimens in refractory metastatic colorectal cancer: characterization of high-response patients by F. Salvà, G. Catani, N. Saoudi, I. Baraibar, J. Ros, M. Rodriguez, C. Salvà de Torres, A. Alcaraz, A. Garcia, R. Comas, F. Ruiz-Pace, A. Rezqallah, R. Dienstmann, J. Tabernero, E. Elez
Published in ESMO Gastrointestinal Oncology (2025-09-01)Get full text
Article
